The role of MYCN in the failure of MYCN amplified neuroblastoma cell lines to G1 arrest after DNA damage

被引:45
作者
Bell, Emma
Premkumar, Rakesh
Carr, Jane
Lu, Xiaohong
Lovat, Penny E.
Kees, Ursula R.
Lunec, John
Tweddle, Deborah A.
机构
[1] Univ Newcastle Upon Tyne, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia
关键词
neuroblastoma; MYCN amplification; G(1) arrest;
D O I
10.4161/cc.5.22.3443
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We previously reported that 3 p53 wild type (wt) MYCN amplified (MNA) neuroblastoma cell lines failed to G(1) arrest after DNA damage despite induction of p53, p21(WAF1) and MDM2. We hypothesised that this was due to high MYCN expression. p53 responses to DNA damage were examined in an additional 13 p53 wt neuroblastoma cell lines. MNA was significantly associated with a failure to G(1) arrest after DNA damage ( p < 0.001) and higher levels of apoptosis after irradiation ( p < 0.05). p21WAF1 and hypophosphorylated ( hypo) RB accumulation post irradiation were significantly lower in cell lines that failed to G(1) arrest ( p < 0.05). Conditional MYCN expression in non-MNA SHEP Tet21N cells did not affect the G(1) arrest after irradiation. MYCN knockdown using siRNA in 3 p53 wt MNA cell lines did not restore a G(1) arrest after irradiation, but increased the baseline G(1) population, p21WAF1 and hypo RB expression. MYCN siRNA also caused a G(1) arrest in a p53 mutant MNA cell line. This study is the first to determine that MNA correlates with a failure to G(1) arrest and attenuated p21WAF1 induction; however MYCN expression alone is not causally responsible.
引用
收藏
页码:2639 / 2647
页数:9
相关论文
共 43 条
  • [1] BIEDLER JL, 1978, CANCER RES, V38, P3751
  • [2] BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO
  • [3] 2-1
  • [4] Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma
    Burkhart, CA
    Cheng, AJ
    Madafiglio, J
    Kavallaris, M
    Mili, M
    Marshall, GM
    Weiss, WA
    Khachigian, LM
    Norris, MD
    Haber, M
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) : 1394 - 1403
  • [5] Increased frequency of aberrations in the p53/MDM2/p14ARF pathway in neuroblastoma cell lines established at relapse
    Carr, J
    Bell, E
    Pearson, ADJ
    Kees, UR
    Beris, H
    Lunec, J
    Tweddle, DA
    [J]. CANCER RESEARCH, 2006, 66 (04) : 2138 - 2145
  • [6] COHN SL, 1991, PROG CLIN BIOL RES, V366, P21
  • [7] A NEW HUMAN HIGHLY TUMORIGENIC NEUROBLASTOMA CELL-LINE WITH UNDETECTABLE EXPRESSION OF N-MYC
    CORNAGLIAFERRARIS, P
    PONZONI, M
    MONTALDO, P
    MARIOTTINI, GL
    DONTI, E
    DIMARTINO, D
    TONINI, GP
    [J]. PEDIATRIC RESEARCH, 1990, 27 (01) : 1 - 6
  • [8] CHROMOSOME ANALYSIS OF HUMAN NEURO-BLASTOMA CELL-LINE TR14 SHOWING DOUBLE MINUTES AND AN ABERRATION INVOLVING CHROMOSOME-1
    COWELL, JK
    RUPNIAK, HT
    [J]. CANCER GENETICS AND CYTOGENETICS, 1983, 9 (03) : 273 - 280
  • [9] FEDER MK, 1983, J NATL CANCER I, V70, P1051
  • [10] FOLEY J, 1991, CANCER RES, V51, P6338